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INTRODUCTION
Xerostomia (dry mouth) is a common symptom
seen in the elderly patients who receive therapeu-
tic irradiation of the head and neck cancer or in
the patients who have Sjögren’s syndrome (SS), a
chronic multisystem immune-mediated disorder
characterized by lymphocytic infiltration into the sali-
vary and lacrimal glands (1). Decrease of salivary se-
cretion can affect numerous aspects of oral function,
contributing to pain, poor diet caries and oral infec-
tions.
In the past decade, pilocarpine, a parasympath-
omimetic agent with muscarinic action, has widely
been used to relieve symptoms of oral dryness (2).
Increase in salivary secretion induced by systemic
administration of pilocarpine is considered to be
mediated by actions on muscarinic cholinergic re-
ceptors in the central nervous system and salivary
glands (3). However, despite the wide clinical use,
the direct action of pilocarpine on salivary glands has
not been defined in detail. In this study, we investi-
gated the effect of pilocarpine on salivary fluid se-
cretion in the isolated, perfused rat submandibular
gland.
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CHARACTERISTICS OF PILOCARPINE-
INDUCED SALIVARY FLUID SECRETION
We examined the effect of various dose of pilo-
carpine (1-1,000 μM) on salivary fluid secretion in
the perfused rat submandibular gland prepared as
described previously (4). Salivary fluid secretion
rate and total saliva volume were increased by pi-
locarpine in a dose-dependent manner. The peak
levels of salivary flow rate and total volume induced
by 1, 10, 100 and 1000 μM pilocarpine were 35.69
21.07, 73.837.53, 89.7410.17 and 76.1215.87
μl/g/min (n=3) and 0.150.09, 0.330.05, 0.39
0.07 and 0.070.02 ml/g/5 min (n=3), respec-
tively. The pattern of pilocarpine-induced salivary
fluid secretion consisted of two phases, a sharply
transient phase and a subsequently sustained phase.
We also examined the effect of carbachol in the per-
fused rat submandibular gland. Although pilocarpine
and carbachol have been reported to be the same
muscarinic agonists, we found that the pattern of the
salivary fluid secretion induced by pilocarpine was
different from that by carbachol in some aspects :
the concentration threshold of carbachol for sali-
vary fluid secretion was lower (200 nM) than that of
pilocarpine, and the maximal response on salivary
fluid secretion induced by carbachol was higher
than that by pilocarpine. Finally, after washout of
stimuli from perfusion to terminate treatment, car-
bachol-stimulated fluid secretion was returned to the
resting level much more rapidly than pilocarpine-
stimulated one.
LESS EFFECT OF TETRODOTOXIN ON
PILOCARPINE-INDUCED SALIVARY FLUID
SECRETION
A whole submandibular gland used for our ex-
periment contains some neuron fibers. To exclude
effect of neurotransmitters released from neurons
in the gland, effect of pilocarpine on salivary fluid
secretion was examined in the presence of tetro-
dotoxin, a specific Na+-channels blocker. When the
submandibular gland was stimulated with pilo-
carpine after pretreatment with 1 μM tetrodotoxin
for 20 min, pilocarpine induced almost complete re-
sponse, indicating that pilocarpine directly stimulates
submandibular gland.
In previous studies, the pilocarpine-evoked saliva
fluid secretion was examined in vivo by intravenous
or intraperitoneal injection or oral administration of
pilocarpine. After administration of pilocarpine, the
plasma concentration of pilocarpine ranging from
4 nM to 0.81 μM induces saliva flow (5-9). In such
experiments, threshold is lower than that in our ex-
periments. Pilocarpine induces saliva flow via acti-
vation of muscarinic receptors at both central nerve
system and gland sites in vivo . Therefore, although
pilocarpine directly stimulates submandibular gland,
salivary fluid secretion appears to be induced by syn-
ergistic effect of pilocarpine on both central nerve
system and gland.
PILOCARPINE-INDUCED INCREASE IN
[Ca2+]i IN DISPERSED SUBMANDIBULAR
GLAND CELLS
It has been considered that the increase in [Ca2+]i
is essential for salivary fluid secretion. Therefore we
examined the effect of pilocarpine on Ca2+ mobiliza-
tion in the dispersed submandibular gland cells,
which were dispersed by collagenase and hyaluroni-
dase (10) and loaded with fura-2 (11). The cells
were stimulated with 1-1000 μM pilocarpine, which
induced saliva secretion. We first carried out such
experiments at 25, but we failed to detect pilo-
carpine-induced Ca2+ mobilization in dispersed sub-
mandibular gland cells, whereas carbachol provoked
Ca2+ mobilization at 25. However, when the tem-
perature was shifted to 37, pilocarpine clearly
induced the increase in [Ca2+]i dose-dependently.
These results suggest that Ca2+-mobilizaing signal-
ing pathway activated by pilocarpine is different from
that by carbachol, which appears to cause the dif-
ference between effects of pilocarpine and carbachol
on the mode of salivary fluid secretion.
PILOCARPINE-INDUCED LUCIFER YEL-
LOW ( LY) SECRETION
It has been considered that water and ions are
supplied from plasma to saliva via two pathways,
transcellular and paracellular pathways. Previous
studies showed the LY is a good tracer that re-
flects salivary fluid flow via paracellular pathway,
because LY traverses the paracellular pathway and
not through transcellular route (12, 13). Then we
examined the effect of pilocarpine on LY secretion
when the gland was perfused with perfusate buffer
with LY. Pilocarpine clearly provoked LY secre-
tion, whereas no LY secretion was observed in the
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absence of pilocarpine. These observations suggest
that paracellular pathway contributes to pilocarpine-
induced salivary fluid secretion.
IN CONCLUSION
We demonstrated that pilocarpine directly stimu-
lates salivary fluid secretion in rat submandibular
gland, in which paracellular pathway contributes to
a part of it. Pilocarpine-induced Ca2+ mobilization
was temperature-dependent, which was different
from the effect of carbachol. The signaling pathway
related to salivary fluid secretion induced by pilo-
carpine appears to be different from that by car-
bachol.
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